Gish claims "gold standard" in oxygenators:
This article was originally published in Clinica
Executive Summary
Gish Biomedical is launching the Vision hollow fibre oxygenator system worldwide. Gish claims that the product uses state-of-the art design and is more effective in situations of high flow rates, low blood volume and substandard physiology associated with multiple system disorders. The company says that the product could become the gold standard for such devices. Gish plans to distribute the Vision in the US itself and use its network of sales distributors.